Interestingly, heteronemin not only showed a strong potency in two estrogen receptor (ER)-positive breast cancer cells (MCF-7 and T-47D), but also exerted a notable antiproliferation in two ER-negative cell lines (MDA-MB-231 and Hs578T) [10, 41]. Here, ESR1 is linked to breast carcinoma.